8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,715) Views
Editor in Chief Professor Garry Walsh
1178-203X
Expert OpinionTowards a new standard of perioperative fluid management
Conor J Shields
Therapeutics and Clinical Risk Management 2008, 4:569-571
22 April 2008
Original Research
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
GL Colombo, GF Altomare, K Peris, P Martini, G Quarta
Therapeutics and Clinical Risk Management 2008, 4:559-568
21 April 2008
Original Research
Nonlinear analysis of the heartbeats in public patient ECGs using an automated PD2i algorithm for risk stratification of arrhythmic death
James E Skinner, Jerry M Anchin, Daniel N Weiss
Therapeutics and Clinical Risk Management 2008, 4:549-557
21 April 2008
Original Research
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Giorgio L Colombo, Sergio Di Matteo, Lluis M Mir
Therapeutics and Clinical Risk Management 2008, 4:541-548
21 April 2008
Review
Managing anemia in lymphoma and multiple myeloma
Gunnar Birgegård
Therapeutics and Clinical Risk Management 2008, 4:527-539
21 April 2008
Review
Leuprorelin depot injection: patient considerations in the management of prostatic cancer
Zinelabidine Abouelfadel, E David Crawford
Therapeutics and Clinical Risk Management 2008, 4:513-526
21 April 2008
Review
A review of nasal polyposis
Jonathan Ray Newton, Kim Wong Ah-See
Therapeutics and Clinical Risk Management 2008, 4:507-512
21 April 2008
Review
Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
Ian N Olver
Therapeutics and Clinical Risk Management 2008, 4:501-506
21 April 2008
Review
Raltegravir: first in class HIV integrase inhibitor
Zelalem Temesgen, Dawd S Siraj
Therapeutics and Clinical Risk Management 2008, 4:493-500
30 June 2008
Review
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
Ruchi Mathur, Olga Levin, Ricardo Azziz
Therapeutics and Clinical Risk Management 2008, 4:487-492
21 April 2008
Review
New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists
Hans P Schlecht, Sarah Schellhorn, Bruce J Dezube, Jeffrey M Jacobson
Therapeutics and Clinical Risk Management 2008, 4:473-485
21 April 2008
Review
Fluticasone furoate nasal spray in the treatment of allergic rhinitis
Pedro Giavina-Bianchi, Rosana Agondi, Rafael Stelmach, Alberto Cukier, Jorge Kalil
Therapeutics and Clinical Risk Management 2008, 4:465-472
21 April 2008
Review
Alemtuzumab in the up-front setting
Matthew Kaufman, Kanti R Rai
Therapeutics and Clinical Risk Management 2008, 4:459-464
21 April 2008
Review
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
Bianca Devitt, Sue-Anne McLachlan
Therapeutics and Clinical Risk Management 2008, 4:453-458
21 April 2008
Review
Review of the combined contraceptive vaginal ring, NuvaRing®
Frans JME Roumen
Therapeutics and Clinical Risk Management 2008, 4:441-451
21 April 2008
Review
Enfuvirtide antiretroviral therapy in HIV-1 infection
Christina MR Kitchen, Miriam Nuño, Scott G Kitchen, Paul Krogstad
Therapeutics and Clinical Risk Management 2008, 4:433-439
21 April 2008
Review
Review of miglustat for clinical management in Gaucher disease type 1
Can Ficicioglu
Therapeutics and Clinical Risk Management 2008, 4:425-431
21 April 2008
Review
Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
Shubham Pant, Meena P Chilukuri, Bhuvaneswari Ramaswamy
Therapeutics and Clinical Risk Management 2008, 4:419-424
21 April 2008
Review
Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology
Sapna Modi, Livia Van, Aron Gewirtzman, Natalia Mendoza, Brenda Bartlett, et al
Therapeutics and Clinical Risk Management 2008, 4:409-417
21 April 2008
Review
Developments in the management of autosomal dominant polycystic kidney disease
Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Mir Reza Bekheirnia, Robert W Schrier
Therapeutics and Clinical Risk Management 2008, 4:393-407
21 April 2008
Review
Update on local anesthetics: focus on levobupivacaine
Crina L Burlacu, Donal J Buggy
Therapeutics and Clinical Risk Management 2008, 4:381-392
21 April 2008
Review
New approaches to managing asthma: a US perspective
William E Berger
Therapeutics and Clinical Risk Management 2008, 4:363-379
21 April 2008
Review
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
F Braido, C Lagasio, IMG Piroddi, I Baiardini, GW Canonica
Therapeutics and Clinical Risk Management 2008, 4:353-361
21 April 2008
Review
Treating psoriasis with adalimumab
Eihab A Alwawi, Stephanie L Mehlis, Kenneth B Gordon
Therapeutics and Clinical Risk Management 2008, 4:345-351
21 April 2008
Review
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
Piet Geusens, Willem Lems
Therapeutics and Clinical Risk Management 2008, 4:337-344
21 April 2008
Review
Treating refractory leukemias in childhood, role of clofarabine
Theresa M Harned, Paul S Gaynon
Therapeutics and Clinical Risk Management 2008, 4:327-336
21 April 2008
Review
Conivaptan: a step forward in the treatment of hyponatremia?
Su Su Hline, Phuong-Truc T Pham, Phuong-Thu T Pham, May H Aung, Phuong-Mai T Pham, Phuong-Chi T Pham
Therapeutics and Clinical Risk Management 2008, 4:315-326
20 April 2008
Review
Zosyn® (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer’s solutions and selected aminoglycosides
Narendra R Desai, Syed M Shah, Jonathan Cohen, Matthew McLaughlin, Hema R Dalal
Therapeutics and Clinical Risk Management 2008, 4:303-314
20 April 2008
Review
“One pill, once daily”: what clinicians need to know about Atripla™
Patrick G Clay, Tracey AH Taylor, Alan G Glaros, MaryPeace McRae, Charlott Williams, et al
Therapeutics and Clinical Risk Management 2008, 4:291-302
20 April 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
